W Health Ventures, a US-based healthcare-focused venture capital firm, has announced a $70 million second fund dedicated to early-stage Indian health startups. With a focus on AI-driven services and single-specialty care delivery, the fund aims to support 8–10 innovative ventures over the next four years.
W Health Ventures, headquartered in Boston, USA, is a venture capital firm specializing in healthcare innovation. The company primarily backs early-stage startups leveraging digital solutions and artificial intelligence to transform medical services. Established in 2019, the firm has been instrumental in nurturing healthcare ventures through capital investment and strategic incubation support.
In its latest move to deepen engagement with India’s growing healthcare ecosystem, W Health Ventures is planning to raise $70 million (approximately ₹610 crore) for its second India-focused fund. The new fund aims to support 8 to 10 seed and early-stage healthcare companies over the next four years, in collaboration with healthcare venture studio 2070 Health.
The venture capital firm plans to invest between ₹26 crore and ₹40 crore ($3–5 million) per company, with reserves allocated for follow-on rounds. The fund adopts a company-creation model, providing not just capital but also infrastructure and operational expertise from the earliest stages. This model is designed to address the regulatory and structural challenges inherent to the healthcare sector and expedite innovation from the ground up.
Fund II will concentrate on two core themes:
- Single-specialty care delivery platforms that offer targeted, high-quality medical services with operational efficiency.
- AI-enabled B2B healthcare solutions aimed at serving the growing demand from US-based healthcare enterprises for intelligent automation and technical services rooted in India’s robust talent base.
Artificial intelligence is positioned as a key enabler across the board—whether in diagnostics, patient care, or backend operations—supporting smarter, more efficient healthcare models globally.
Deployment from the new fund has already begun. The first investment has been made in EverHope Oncology, a next-gen cancer care startup that raised $10 million in seed funding. The round was led by W Health in collaboration with Narayana Health and 2070 Health.
The firm’s first fund, totaling around $50 million, successfully backed ventures like Wysa (an AI-powered mental health platform), Elevate Now (a medical weight-loss program), and Kins (a US-based virtual physical therapy service). Other investments covered areas such as pediatric care and pain management.
W Health’s growing presence in India reflects a larger trend of sector-specific venture capital strategies emerging in the country, particularly in healthtech, deeptech, and consumer innovation.
READ MORE ON
